Venus Remedies Ltd

Venus Remedies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Venus Remedies Ltd

₹ 230 -4.75%
05 Jun 3:23 p.m.
venusremedies.com BSE: 526953 NSE : VENUSREM
About

Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the business of pharmaceutical products manufacturing.[1]

Key Points

Therapeutic Areas
The company manufactures and sells a very wide range of pharmaceutical products in therapeutic segments like Anti-infective (antibiotics), oncology, neurology, pain management, skin & wound care, anti-microbial resistance, etc.[1]

Website BSE NSE
  • Market Cap ₹ 307 Cr.
  • Current Price ₹ 230
  • High / Low ₹ 264 / 145
  • Stock P/E 10.6
  • Book Value ₹ 358
  • Dividend Yield 0.00 %
  • ROCE 8.03 %
  • ROE 6.24 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.65 times its book value
  • Company has delivered good profit growth of 25.3% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 8.77% over last 3 years.
  • Debtor days have increased from 29.6 to 57.6 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
79.22 179.71 118.41 114.07 102.44 136.85 192.64 117.44 128.77 154.93 124.75 109.63 148.53
72.82 158.92 113.25 101.03 94.57 117.50 164.71 103.21 121.46 136.68 109.58 102.55 127.50
Operating Profit 6.40 20.79 5.16 13.04 7.87 19.35 27.93 14.23 7.31 18.25 15.17 7.08 21.03
OPM % 8.08% 11.57% 4.36% 11.43% 7.68% 14.14% 14.50% 12.12% 5.68% 11.78% 12.16% 6.46% 14.16%
-7.99 -7.66 19.33 5.62 23.92 1.92 2.97 1.07 2.47 1.41 1.77 3.75 3.24
Interest -1.88 2.79 7.33 1.73 0.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 6.22 8.33 8.35 8.42 9.18 8.36 8.46 8.40 7.36 7.57 8.77 6.97 8.06
Profit before tax -5.93 2.01 8.81 8.51 21.74 12.91 22.44 6.90 2.42 12.09 8.17 3.86 16.21
Tax % -13.83% 0.00% 16.91% 25.97% -77.78% -13.01% -7.53% -13.77% 0.00% 8.27% 5.39% 32.38% 53.49%
Net Profit -6.74 2.01 7.33 6.29 38.65 14.59 24.13 7.85 2.42 11.09 7.73 2.61 7.54
EPS in Rs -5.46 1.63 5.94 5.10 31.32 10.91 18.05 5.87 1.81 8.30 5.78 1.95 5.64
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
397 452 515 443 392 375 355 299 316 511 572 538
291 333 382 356 312 328 312 265 273 464 503 476
Operating Profit 106 118 133 87 80 47 44 34 43 47 69 62
OPM % 27% 26% 26% 20% 20% 13% 12% 11% 14% 9% 12% 11%
0 0 0 1 1 1 1 -4 -5 41 8 10
Interest 27 24 29 41 37 34 35 25 13 13 0 0
Depreciation 24 32 39 45 40 39 33 33 31 34 33 31
Profit before tax 55 63 66 2 3 -25 -23 -28 -6 41 45 40
Tax % 9% 9% 7% -123% 60% 18% -13% 4% -31% -32% -10% 28%
Net Profit 50 57 61 5 1 -20 -27 -27 -8 54 49 29
EPS in Rs 51.35 54.21 53.27 3.98 1.05 -16.40 -21.54 -21.97 -6.67 43.97 36.65 21.67
Dividend Payout % 6% 6% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 2%
5 Years: 9%
3 Years: 19%
TTM: -6%
Compounded Profit Growth
10 Years: -7%
5 Years: 25%
3 Years: 184%
TTM: -41%
Stock Price CAGR
10 Years: -2%
5 Years: 35%
3 Years: 69%
1 Year: 6%
Return on Equity
10 Years: 3%
5 Years: 5%
3 Years: 9%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
10 11 11 11 11 12 12 12 12 12 13 13
Reserves 300 377 456 455 433 382 356 329 320 374 436 465
220 271 288 319 327 308 302 294 216 48 39 39
56 71 81 60 63 65 78 97 96 113 91 92
Total Liabilities 587 729 836 845 834 767 748 732 644 547 579 609
336 381 416 426 434 389 370 347 271 244 225 200
CWIP 23 48 68 78 80 66 65 65 25 25 25 26
Investments 29 29 29 29 29 29 0 0 0 0 0 20
199 272 323 312 291 283 314 320 348 277 329 363
Total Assets 587 729 836 845 834 767 748 732 644 547 579 609

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
38 51 53 67 42 62 52 44 78 132 41 28
-94 -102 -94 -67 3 -18 -11 -11 -5 56 -17 -51
56 55 39 -0 -46 -44 -40 -35 -72 -162 -9 0
Net Cash Flow 0 3 -2 -1 -0 0 0 -2 1 26 15 -23

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 41 43 44 49 50 41 45 38 34 12 19 58
Inventory Days 155 175 173 189 210 230 242 283 282 130 122 123
Days Payable 20 25 34 35 36 50 48 67 70 74 48 53
Cash Conversion Cycle 176 193 183 203 223 220 239 254 246 67 93 128
Working Capital Days 91 104 118 149 180 164 143 130 171 68 84 131
ROCE % 17% 15% 13% 6% 5% 1% 2% 1% 3% 6% 10% 8%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
35.89 35.89 35.89 35.89 40.81 40.81 40.81 40.81 41.76 41.76 41.76 41.76
0.04 0.04 0.04 0.04 0.02 0.10 0.28 0.33 0.96 1.13 1.07 1.00
64.07 64.07 64.07 64.07 59.17 59.09 58.91 58.86 57.28 57.11 57.19 57.26

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings